Inactive Instrument

Apotheca Biosciences, Inc.

Equities

CBDC

US03836L1070

Biotechnology & Medical Research

Apotheca Biosciences Announces Addition of Dr. Herbert Weissbach to the Cannabis Scientific Advisory Board

November 01, 2018 at 05:50 pm IST

Apotheca Biosciences announced the addition of Dr. Herbert Weissbach to the Scientific Advisory Board of Apotheca Biosciences as Scientific and Strategic Advisor. Dr. Weissbach is Professor Emeritus at the Center for Molecular Biology and Biotechnology (CMBB) at Florida Atlantic University (FAU).

Latest news about Apotheca Biosciences, Inc.

Apotheca Biosciences, Inc. cancelled the acquisition of 51% of Hemp Bloom LLC.	20/20/20	CI
Apotheca Biosciences, Inc. Announces Resignation of P.C. Sundareswaran as the Chairman and CEO	09/19/09	CI
Deirdre Fernandes Resigns as VP of Operations and Director of Apotheca Biosciences, Inc	02/19/02	CI
Apotheca Biosciences, Inc. signed a definitive agreement to acquire 51% of Hemp Bloom LLC.	21/19/21	CI
Apotheca Biosciences, Inc. Reports Earnings Results for the First Quarter Ended April 30, 2019	20/19/20	CI
Apotheca Biosciences Introduces XKAPE by ProMED, Newest Product Line Designed for Independent Grocers & Convenience Stores	18/19/18	CI
Apotheca Biosciences, Inc. Announces Resignation of Verghese from Chief Technical Officer and Director	01/19/01	CI
Apotheca Biosciences, Inc. will Change its Ticker to CBDC from PCFP	04/19/04	CI
Apotheca Biosciences Announces the Incorporation of Its Newly Created Subsidiary ProMED Biosciences, Inc	01/19/01	CI
Apotheca Biosciences, Inc. Appoints P.C. Sundar as its Chairman & CEO	06/19/06	CI
Apotheca Biosciences Introduces ProMED	15/19/15	CI
Apotheca Biosciences, Inc. Announces Management Changes	12/18/12	CI
Apotheca Biosciences Signs an LOI For Purchase of Nano Creaciones S.A. P.I. de C.V	06/18/06	CI
Apotheca Biosciences Announces Addition of Dr. Herbert Weissbach to the Cannabis Scientific Advisory Board	01/18/01	CI
Apotheca Biosciences Announces the Addition of Malireddy Srinivasulu Reddy to its Research Team as Chief Medical Advisor	15/18/15	CI
Apotheca Biosciences and CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High	08/18/08	CI
Apotheca Biosciences Inc. Overviews GameDayRx, CBD & Cannabis Tailor-Made for Athletes	27/18/27	CI
Cannabis Leaf, Inc. will Change its Name to Apotheca Biosciences, Inc	24/18/24	CI
Cannabis Leaf Incorporated Announces Board Changes	12/18/12	CI
Apotheca Biosciences, Inc. completed the acquisition of Cannabis Leaf, Inc. in a reverse merger transaction.	25/18/25	CI
Apotheca Biosciences Inc. Announces RAPID Launching	05/18/05	CI
Cannabis Leaf Secures the IP Rights for Pain Patch, Apotheca Biosciences’ Pain Alleviation Technology	08/18/08	CI
Apotheca Biosciences, Inc. entered into an agreement to acquire Cannabis Leaf, Inc. in a reverse merger transaction.	07/18/07	CI
FutureLand, Corp. acquired 20% stake in Apotheca Biosciences, Inc. from CB Scientific, Inc..	18/17/18	CI

Chart Apotheca Biosciences, Inc.

Duration

Period

More charts

Company Profile

Apotheca Biosciences, Inc., formerly Cannabis Leaf Inc., is a medical device company. The Company is developing engineering and device solutions for cannabinoid medical technologies. It is focused on developing medical products and nutraceuticals and formulates and delivers technologies. The Company serves healthcare and consumer care industry. The Company's products include transdermal and sublingual. It also provides nasal delivery technologies for precise and controlled dosing of cannabinoids. Its pipeline products includes, transdermal, sublingual, and nasal delivery technologies.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+29.77%	49.18B
IQVIA HOLDINGS INC.	+1.00%	42.11B
LONZA GROUP AG	+50.47%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.71B
BIO-TECHNE CORPORATION	+8.22%	13.26B
MEDPACE HOLDINGS, INC.	+32.41%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.62%	11.99B

Other Biotechnology & Medical Research